跳至主要内容
临床试验/NCT00576394
NCT00576394已完成1 期

Impact of Aggressive Versus Moderate Glycemic Control on Clinical Outcomes Following Coronary Artery Bypass Graft Surgery in Diabetic Patients

American Heart Association1 个研究点 分布在 1 个国家目标入组 108 人开始时间: 2006年10月最近更新:
适应症
干预措施

试验速览

阶段
1 期
状态
已完成
入组人数
108
试验地点
1
主要终点
Incidence of Hypoglycemia

研究概览

简要总结

entGlycemic control has been found to improve clinical outcomes following Coronary Bypass Surgery. This study tests the hypothesis that obtaining tighter glycemic control(80-120mg/dl) as opposed to more moderate control (120-180mg/dl) will further improve outcomes.

详细描述

150 diabetic patients will be randomized to achieve aggressive glycemic control (80-120mg/dl) vs moderate control (120-180mg/dl) using intravenous insulin infusions beginning at anesthetic induction and continuing for 18 hours following surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All diabetic patients undergoing Coronary Bypass Surgery

排除标准

  • Patients with hepatic and renal failure

研究组 & 干预措施

1Moderate Glycemic Control

Active Comparator

Patients will receive an insulin drip to keep blood glucose levels between 120-180mg/dl

干预措施: IV Insulin drip (Drug)

2Aggressive Glycemic Control

Active Comparator

Patients will receive an insulin drip designed to maintain serum glucose between 80-120mg/dl

干预措施: Insulin (Drug)

结局指标

主要结局

Incidence of Hypoglycemia

时间窗: 24 hours following surgery

次要结局

  • free fatty acid levels(24 hours following surgery)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Harold L. Lazar MD

Professor of Cardiothoracic Surgery

American Heart Association

研究点 (1)

Loading locations...

相似试验